Epidemiological studies of cognitive impairment and dementia across Eastern and Middle European countries (epidemiology of dementia in Eastern and Middle European Countries)

Kiejna, Andrzej; Frydecka, Dorota; Adamowski, Tomasz; Bickel, Horst; Reynish, Emma; Prince, Martin; Caracciolo, Barbara; Fratiglioni, Laura; Georges, Jean

doi:10.1002/gps.2511

Cited by 24 publications

(23 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…If this was indeed the case, it does not seem to have affected the intruments' reliability, validity and sensitivity for the present sample. However, in future studies it would be interesting to explicitly include older adults with mild/moderate cognitive impairments, given their high prevalence in the older population (e.g., Kiejna et al, 2011).…”

Section: Limitations and Implications For Further Researchmentioning

confidence: 99%

Older adults’ preferences for formal social support of autonomy and dependence in pain: development and validation of a scale

2017

View full text Add to dashboard Cite

Tel.: +351217903210 Word count: 5711words AcknowledgementsWe would like to thank Prof. Helena Carvalho for her help with statistics. This study was partially funded by Fundação para a Ciência e Tecnologia (SFRH/BD/79145/2011). We declare that there were no financial or other relationships that lead to conflicts of interest in the development of this research. The scale showed good test-retest reliability, sensitivity and discriminant and concurrent validity; the higher the preferences for dependence support the higher the desire for dependence (r=.33) and the lower the desire for independence (r=-.41). The PFSSADI is an innovative tool, which may contribute to explore the role of pain-related social support responsiveness on the promotion of older adults' functional autonomy when in pain.

show abstract

Section: Limitations and Implications For Further Researchmentioning

confidence: 99%

Older adults’ preferences for formal social support of autonomy and dependence in pain: development and validation of a scale

2017

View full text Add to dashboard Cite

show abstract

“…13,15 Patients with dementia in the acute setting are generally considered to impose higher costs on the health system. This is reflected in longer length of stay (LOS) compared to those the same age without the disease, 7,12,16,17,20,[22][23][24][25][26][27][28][29][30][31][32][33] increased risk of in-hospital complications, 21,34 safety and behavioural issues requiring 1:1 care, and a higher risk of readmission. 21 However, many of these studies that explore the economic impact of the disease extrapolate estimates based on the costs of formally diagnosed patients only.…”

Section: Introductionmentioning

confidence: 99%

Dementia in older people admitted to hospital: An analysis of length of stay and associated costs

Ahern

Cronin

Woods

et al. 2018

Int J Geriat Psychiatry

View full text Add to dashboard Cite

Objectives Patients with dementia in the acute setting are generally considered to impose higher costs on the health system compared to those without the disease largely due to longer length of stay (LOS). Many studies exploring the economic impact of the disease extrapolate estimates based on the costs of patients diagnosed using routinely collected hospital discharge data only. However, much dementia is undiagnosed, and therefore in limiting the analysis to this cohort, we believe that LOS and the associated costs of dementia may be overestimated. We examined LOS and associated costs in a cohort of patients specifically screened for dementia in the hospital setting. Methods Using primary data collected from a prospective observational study of patients aged ≥70 years, we conducted a comparative analysis of LOS and associated hospital costs for patients with and without a diagnosis of dementia. Results There was no significant difference in overall length of stay and total costs between those with (μ = 9.9 days, μ = € 8246) and without (μ = 8.25 days, μ = € 6855) dementia. Categorical data analysis of LOS and costs between the two groups provided mixed results. Conclusions The results challenge the basis for estimating the costs of dementia in the acute setting using LOS data from only those patients with a formal dementia diagnosis identified by routinely collected hospital discharge data. Accurate disease prevalence data, encompassing all stages of disease severity, are required to enable an estimation of the true costs of dementia in the acute setting based on LOS.

show abstract

“…Similar to several other countries (Kiejna et al 2010), Ireland lacks reliable epidemiological data on dementia prevalence rates, although earlier estimates based on standardised or EURODEM prevalence rates, linked to European population-based studies, are available (Government of Ireland, 2006;O'Shea, 2007;Diaz-Ponce, 2008). New dementia prevalence rates from the latest metaanalysis project in Europe are now available from the European Collaboration on Dementia (EuroCoDe) (Alzheimer Europe, 2009) (see Table 1) and have been used in this study to provide improved estimates of dementia prevalence for Ireland.…”

Section: Introductionmentioning

confidence: 99%

Planning dementia services: new estimates of current and future prevalence rates of dementia for Ireland

Pierce

Cahill

O’Shea

2013

Ir. j. psychol. Med.

View full text Add to dashboard Cite

Objectives. The paper provides new estimates of dementia prevalence at a national and local level in Ireland and new projections of future numbers of people with dementia.Methods. The prevalence of dementia at a national and local level has been calculated by applying European Collaboration on Dementia (EuroCoDe) prevalence rates to data from the Census of Population 2006. The National Disability Survey has been used to estimate the number of people with Down syndrome and dementia. Projections of future numbers of people with dementia have been calculated by applying EuroCoDe prevalence rates to the most recently available population projections from the Central Statistics Office (CSO).Results. It is estimated that there were 41 740 people with dementia in Ireland in 2006. Estimates show that there are clear regional differences in prevalence of dementia across Ireland, with the largest proportion of people with dementia in the West of Ireland, and the Dublin North Eastern region having the lowest share of dementia. Our best estimate is that there are 700 people with Down syndrome and dementia in Ireland. Applying EuroCoDe prevalence rates to the most recent CSO population projections shows that the prevalence of dementia in Ireland will increase to between 67 493 and 70 000 in 2021 and to between 140 580 and 147 000 in 2041.Conclusions. Although there are several limitations to these estimates, the data provide timely and useful information for planning effective health and social care services, as well as raising public and professional awareness about dementia at a national level.

show abstract

Epidemiological studies of cognitive impairment and dementia across Eastern and Middle European countries (epidemiology of dementia in Eastern and Middle European Countries)

Abstract: There is strong need for epidemiological studies in Eastern and Middle Europe, as well as for greater coordination and standardization of methods to improve the quality and comparability of epidemiological data to determine the prevalences' rates of dementia in all the EU countries.

Cited by 24 publications

References 20 publications

Older adults’ preferences for formal social support of autonomy and dependence in pain: development and validation of a scale

Older adults’ preferences for formal social support of autonomy and dependence in pain: development and validation of a scale

Dementia in older people admitted to hospital: An analysis of length of stay and associated costs

Planning dementia services: new estimates of current and future prevalence rates of dementia for Ireland

Contact Info

Product

Resources

About